Astrazeneca Plc Stock Filter Stocks by Fundamentals
| ZEGA Stock | EUR 63.50 1.00 1.60% |
AstraZeneca PLC fundamentals help investors to digest information that contributes to AstraZeneca PLC's financial success or failures. It also enables traders to predict the movement of AstraZeneca Stock. The fundamental analysis module provides a way to measure AstraZeneca PLC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AstraZeneca PLC stock.
AstraZeneca |
Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
| All Next | Launch Module |
AstraZeneca Fundamentals
| Return On Equity | 0.0863 | |||
| Return On Asset | 0.0555 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 228.75 B | |||
| Shares Outstanding | 3.1 B | |||
| Shares Owned By Insiders | 0.04 % | |||
| Shares Owned By Institutions | 17.72 % | |||
| Price To Earning | 45.09 X | |||
| Price To Book | 6.10 X | |||
| Price To Sales | 4.39 X | |||
| Revenue | 44.35 B | |||
| Gross Profit | 35.73 B | |||
| EBITDA | 9.09 B | |||
| Net Income | 3.29 B | |||
| Cash And Equivalents | 6.25 B | |||
| Cash Per Share | 2.38 X | |||
| Total Debt | 22.96 B | |||
| Debt To Equity | 144.40 % | |||
| Current Ratio | 0.95 X | |||
| Book Value Per Share | 11.95 X | |||
| Cash Flow From Operations | 9.81 B | |||
| Earnings Per Share | 0.99 X | |||
| Price To Earnings To Growth | 1.35 X | |||
| Target Price | 69.28 | |||
| Number Of Employees | 83.5 K | |||
| Beta | 0.19 | |||
| Market Capitalization | 194.57 B | |||
| Total Asset | 96.48 B | |||
| Z Score | 4.8 | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 4.30 % | |||
| Net Asset | 96.48 B | |||
| Last Dividend Paid | 2.9 |
About AstraZeneca PLC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AstraZeneca PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AstraZeneca PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AstraZeneca PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in AstraZeneca Stock
AstraZeneca PLC financial ratios help investors to determine whether AstraZeneca Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AstraZeneca with respect to the benefits of owning AstraZeneca PLC security.